The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease
Open accessAbstract
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) damages the nigrostriatal dopaminergic pathway as seen in Parkinson's disease (PD), a common neurodegenerative disorder with no effective protective treatment. Consistent with a role of glial cells in PD neurodegeneration, here we show that minocycline, an approved tetracycline derivative that inhibits microglial activation independently of its antimicrobial properties, mitigates both the demise of nigrostriatal dopaminergic neurons and the formation of nitrotyrosine produced by MPTP. In addition, we show that minocycline not only prevents MPTP-induced activation of microglia but also the formation of mature interleukin-1beta and the activation of NADPH-oxidase and inducible nitric oxide synthase (iNOS), three key microglial-derived cytotoxic mediators. Previously, we demonstrated that ablation of iNOS attenuates MPTP-induced neurotoxicity. Now, we demonstrate that iNOS is not the only microglial-related culprit implicated in MPTP-induced toxicity because mutant iNOS-deficient mice treated with minocycline are more resistant to this neurotoxin than iNOS-deficient mice not treated with minocycline. This study demonstrates that microglial-related inflammatory events play a significant role in the MPTP neurotoxic process and suggests that minocycline may be a valuable neuroprotective agent for the treatment of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect is mainly ascribable to the minocycline-dependent suppression of microglia activation, which has been reported by several in vivo studies [251,258,259,260,261,262,263].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Free Radicals in Biology and Medicine
Land, E. J. (1990) · International Journal of Radiation Biology · doi:10.1080/09553009014552071 · Cited by 4,871
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Microglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,111
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 19×
“…decreases MPTP-mediated nitrotyrosine formation A significant part of the MPTP neurotoxic process is mediated by NO-related oxidative damage (Przedborski et al., 2000), the extent of which can be evaluated by assessing nitrotyrosine levels (Liberatore et al., 1999; Pennathur et al., 1999).”
BackgroundMethodResultInfluentialYrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,032
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Research works printed but not linked: 1
- Fahn S, Przedborski S (2000) Parkinsonism. In: Merritt's neurology (Rowland LP, ed), pp 679 -693. New York: Lippincott Williams & Wilkins.
Cited by
Sorted by citations
Items 801–900 of 999
Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
Lim, S., Kim, H., Kim, D., & Lee, S. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.010 · Cited by 28
Ferrari, D. P., Bortolanza, M., & Bel, E. A. D. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00345-x · Cited by 27
Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease
Scheller, D., Stichel-Gunkel, C. C., Lübbert, H., Porras, G., Ravenscroft, P., Hill, M. P., & Bézard, E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.001 · Cited by 27
Strahan, J. A., Walker, W. H., Montgomery, T. R., & Forger, N. G. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22457 · Cited by 26
Vidyadhara, D. J., Yarreiphang, H., Raju, T. R., & Alladi, P. A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0158-y · Cited by 27
Antineuroinflammation of Minocycline in Stroke
Chen, Y., Cai, Z., & Ke, Z. (2017) · The Neurologist · doi:10.1097/nrl.0000000000000136 · Cited by 27
Yoon, J. S., Jeong, E. J., Yang, H., Kim, S. H., Sung, S. H., & Kim, Y. C. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.598151 · Cited by 27
Ogawa, Y., Sano, T., Irisa, M., Kodama, T., Saito, T., Furusawa, E., Kaizu, K., Yanagi, Y., Tsukimura, T., Togawa, T., et al. (2017) · Scientific Reports · doi:10.1038/srep40518 · Cited by 27
Shen, Y., Hébert, G. A., Lin, L.-Y., Luo, Y., Moze, E., Li, K., & Neveu, P. J. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.011 · Cited by 27
GCH1 deficiency activates brain innate immune response and impairs tyrosine hydroxylase homeostasis
Larbalestier, H., Keatinge, M., Watson, L., White, E., Gowda, S., Wei, W., Koler, K., Semenova, S., Elkin, A., Rimmer, N., et al. (2022) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 26
Therapeutic potential of lipid nanosystems for the treatment of Parkinson’s disease
Preetam, S., Jonnalagadda, S., Kumar, L., Rath, R., Chattopadhyay, S., Alghamdi, B. S. A., Abuzenadah, A. M., Jha, N. K., Gautam, A., Malik, S., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101965 · Cited by 28
Son, H. J., Lee, J. A., Shin, N., Choi, J. H., Seo, J. W., Yoon, D., Lee, C.-S., Kim, E., Choe, H., & Hwang, O. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01692.x · Cited by 26
Jayaraj, R. L., Elangovan, N., Dhanalakshmi, C., Manivasagam, T., & Essa, M. M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.06.022 · Cited by 26
Pappas, S. S., Behrouz, B., Janis, K. L., Goudreau, J. L., & Lookingland, K. J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.010 · Cited by 25
Bian, M., Li, L., Yu, M., Fei, J., & Huang, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.030 · Cited by 27
Yang, Y., Zhang, S., Ding, J., Zhou, F., & Hu, G. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009243 · Cited by 26
Mondal, S., Rangasamy, S. B., Roy, A., Dasarathi, S., Kordower, J. H., & Pahan, K. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800587 · Cited by 27
NeuroAIDS, Drug Abuse, and Inflammation: Building Collaborative Research Activities
Berman, J. W., Carson, M. J., Chang, L., Cox, B. M., Fox, H. S., González, R. G., Hanson, G. R., Hauser, K. F., Ho, W., Hong, J., et al. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9048-9 · Cited by 25
Lee, J. A., Son, H. J., Park, K. D., Han, S. H., Shin, N., Kim, J. H., Kim, H. R., Kim, D. J., & Hwang, O. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9550-z · Cited by 25
Genetic analysis of the S100B gene in Chinese patients with Parkinson disease
Guo, Y., Yang, H., Deng, X., Song, Z. J., Yang, Z., Xiong, W., Yuan, L., Xu, H., Deng, S., & Deng, H. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.037 · Cited by 25
Kostuk, E. W., Cai, J., & Iacovitti, L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1181-x · Cited by 26
Prydz, A., Stahl, K., Zahl, S., Skauli, N., Skare, Ø., Ottersen, O. P., & Amiry-Moghaddam, M. R. (2020) · Cells · doi:10.3390/cells9112418 · Cited by 26
Si, Y., Zhang, Y., Liu, H., Chen, L., Xu, Y., Sun, F., Ji, M., Yang, J., & Bao, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164763 · Cited by 26
Blockade of chloride intracellular ion channel 1 stimulates Aβ phagocytosis
Paradisi, S., Matteucci, A., Fabrizi, C., Denti, M. A., Abeti, R., Breit, S. N., Malchiodi‐Albedi, F., & Mazzanti, M. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21693 · Cited by 25
Hippocampal proliferation is increased in presymptomatic Parkinson’s disease and due to microglia
Doorn, K. J., Drukarch, B., van Dam, A.-M., & Lucassen, P. J. (2014) · Neural Plasticity · doi:10.1155/2014/959154 · Cited by 24
Kay, G. W., & Palmer, D. N. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-97 · Cited by 24
AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
Marino, M., & Holt, M. G. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.870799 · Cited by 24
Tourville, A., Viguier, S., González‐Lizárraga, F., Tomas‐Grau, R. H., Ramírez, P., Brunel, J. M., Pereira, M. D. S., Bel, E. A. D., Chehín, R. N., Ferrié, L., et al. (2023) · Antioxidants · doi:10.3390/antiox12030575 · Cited by 24
Doxycycline Attenuates Peripheral Inflammation in Rat Experimental Autoimmune Neuritis
Yi, C., Zhang, Z., Wang, W., Zug, C., Schluesener, H. J., & Zhang, Z. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0522-2 · Cited by 23
Roles of glial cells in neuroinflammation and neurodegeneration
Takeuchi, H. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12059 · Cited by 27
Ago, Y., Kawasaki, T., Nashida, T., Ota, Y., Cong, Y., Kitamoto, M., Takahashi, T., Takuma, K., & Matsuda, T. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.041 · Cited by 24
Hwang, H., Lee, S., Lee, W., Lee, H., & Suk, K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22378 · Cited by 24
Yeung, P. K. K., Lai, A. K. W., Son, H. J., Zhang, X., Hwang, O., Chung, S. S. M., & Chung, S. K. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.008 · Cited by 25
Lu, Y., Giri, P. K., Lei, S., Zheng, J., Li, W., Wang, N., Chen, X., Lü, H., Zuo, Z., Liu, Y., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.03.057 · Cited by 24
Differential Mechanisms of Nitric Oxide- and Peroxynitrite-Induced Cell Death
Meij, J. T. A., Haselton, C. L., Hillman, K. L., Dhanasekaran, M., Ebadi, M., & Yu, L. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001354 · Cited by 24
Shibata, H., Katsuki, H., Okawara, M., Kume, T., & Akaike, A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20700 · Cited by 24
Östergren, A., Fredriksson, A., & Brittebo, E. B. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0334-0 · Cited by 24
Giri, P. K., Lu, Y., Lei, S., Li, W., Zheng, J., Lü, H., Chen, X., Liu, Y., & Zhang, P. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000937 · Cited by 21
Sharma, P. K., Kishore, A., De, I., Negi, S., Kumar, G., Bhardwaj, S., & Singh, M. P. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105604 · Cited by 24
Hull, A. J., Atilano, M. L., Gergi, L., & Kinghorn, K. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0381 · Cited by 24
Cieślik, M., Pyszko, J., & Strosznajder, J. B. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.016 · Cited by 23
Khan, M. M., Zaheer, S. A., Thangavel, R., Patel, M., Kempuraj, D., & Zaheer, A. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1553-x · Cited by 23
VEGFR-1 Signaling Regulates the Homing of Bone Marrow-Derived Cells in a Mouse Stroke Model
Beck, H., Raab, S., Copanaki, E., Heil, M., Scholz, A., Shibuya, M., Deller, T., Machein, M. R., & Plate, K. H. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c9c05b · Cited by 23
Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model
Russmann, V., Goc, J., Boes, K., Ongerth, T., Salvamoser, J. D., Siegl, C., & Potschka, H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.002 · Cited by 23
Fendrick, S. E., Miller, K. R., & Streit, W. J. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.05.047 · Cited by 23
Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice
Liu, J., Wang, M., Gu, P., Ma, Q., Wang, Y.-Y., Geng, Y., Yuan, Z.-Y., Cui, D., Zhang, Z., Ma, L., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.043 · Cited by 23
Yan, K., Zhang, R., Chen, L., Chen, F., Liu, Y., Peng, L., Sun, H., Huang, W., Sun, C., Lv, B., et al. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.041 · Cited by 23
Chemotactic and Cytotoxic Effects of Minocycline on Human Retinal Pigment Epithelial Cells
Hollborn, M., Wiedemann, P., Bringmann, A., & Kohen, L. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4661 · Cited by 22
Koulaeinejad, N., Haddadi, K., Ehteshami, S., Shafizad, M., Salehifar, E., Emadian, O., Mohammadpour, R. A., & Ala, S. (2019) · PubMed Central · doi:10.22037/ijpr.2019.1100677 · Cited by 22
Nakamura, Y., Kimura, S., Takada, N., Takemura, M., Iwamoto, M., Hisaoka-Nakashima, K., Nakata, Y., & Morioka, N. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104751 · Cited by 18
Tiwari, P. C., Chaudhary, M. J., Pal, R., Kartik, S., & Nath, R. (2021) · Annals of Neurosciences · doi:10.1177/09727531211051976 · Cited by 23
Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
Blagov, A. V., Postnov, A. Y., Sukhorukov, V. N., Popov, M. A., Uzokov, J., & Orekhov, A. N. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901036 · Cited by 26
Ossola, B., Lantto, T. A., Puttonen, K. A., Tuominen, R. K., Raasmaja, A., & Männistö, P. T. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22791 · Cited by 22
Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity
Liang, Y., Li, S., Guo, Q., Zhang, Y., Wen, C., Zou, Q., & Su, B. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.033 · Cited by 22
Tristão, F. S. M., Lazzarini, M., Martin, S., Amar, M., Stühmer, W., Kirchhoff, F., Gomes, L. C., Lanfumey, L., Prediger, R. D., Sepulveda-Diaz, J. E., et al. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9557-5 · Cited by 22
Remodeling microglia to a protective phenotype in Parkinson’s disease?
Awogbindin, I. O., Ishola, I. O., St‐Pierre, M., Carrier, M., Savage, J. C., Paolo, T. D., & Tremblay, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135164 · Cited by 21
Boger, H. A., Middaugh, L. D., Granholm, A., & McGinty, J. F. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.013 · Cited by 22
Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease
Tripathy, D., Chakraborty, J., & Mohanakumar, K. P. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1045505 · Cited by 21
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 21
Romero‐Miguel, D., Casquero‐Veiga, M., MacDowell, K. S., Torres-Sánchez, S., Garcia-Partida, J. A., Lamanna‐Rama, N., Romero‐Miranda, A., Berrocoso, E., Leza, J. C., Desco, M., et al. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab036 · Cited by 21
Emerging Roles for Aberrant Astrocytic Calcium Signals in Parkinson’s Disease
Bancroft, E. A., & Srinivasan, R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.812212 · Cited by 22
Yokoyama, H., Yano, R., Aoki, E., Kato, H., & Araki, T. (2008) · Metabolic Brain Disease · doi:10.1007/s11011-008-9096-3 · Cited by 21
Oeckl, P., Lattke, M., Wirth, T., Baumann, B., & Ferger, B. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.010 · Cited by 24
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
Licker, V., & Burkhard, P. R. (2014) · Translational Proteomics · doi:10.1016/j.trprot.2014.08.001 · Cited by 21
Buonaguro, E. F., Tomasetti, C., Chiodini, P., Marmo, F., Latte, G., Rossi, R., Avvisati, L., Iasevoli, F., & de Bartolomeis, A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116658987 · Cited by 21
Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease
Roussakis, A., & Piccini, P. P. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.08.009 · Cited by 23
Gan, P., Xia, Q., Hang, G., Zhou, Y., Qian, X., Wang, X., & Ding, L. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13052 · Cited by 21
Yuan, Q., Chen, X., Wang, W., Li, J., Wang, X., Tang, Z., Xu, J., Lin, H. Y., Yang, Z., Li, L., et al. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13149 · Cited by 21
Delayed Treatment with Arundic Acid Reduces the MPTP-induced Neurotoxicity in Mice
Oki, C., Watanabe, Y., Yokoyama, H., Shimoda, T., Kato, H., & Araki, T. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9241-2 · Cited by 21
Kawashita, E., Tsuji, D., Kawashima, N., Nakayama, K., Matsuno, H., & Itoh, K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06041.x · Cited by 21
Minocycline Inhibits ICAD Degradation and the NF-ΚB Activation Induced by 6-OHDA in PC12 Cells
Jiang, B.-P., Le, L., Xu, L.-J., & Xiao, P.-G. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.001 · Cited by 19
A Novel Long-Noncoding RNA LncZFAS1 Prevents MPP+-Induced Neuroinflammation Through MIB1 Activation
Zhu, Z., Huang, P., Sun, R., Li, X., Li, W., & Gong, W. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02619-z · Cited by 20
Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
Amerio, A., Magnani, L., Arduino, G., Fesce, F., de Filippis, R., Parise, A., Costanza, A., Nguyen, K. D., Saverino, D., Berardis, D. D., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231128101725 · Cited by 21
Marek, D., Papin, S., Ellefsen, K., Niederhäuser, J., Isidor, N., Ransijn, A., Poupon, L., Spertini, F., Pantaleo, G., Bergmann, S., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-238 · Cited by 20
Liu, X., Su, H., Chu, T., Guo, A., & Wu, W. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.03.011 · Cited by 20
Huang, C.-F., Li, G., Ma, R., Sun, S., & Chen, J. (2008) · Neuroscience Bulletin · doi:10.1007/s12264-008-0066-x · Cited by 20
Studies of Depression-Related States in Animal Models of Parkinsonism
Schintu, N., Zhang, X., & Svenningsson, P. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-2012-12076 · Cited by 21
Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy
Strong, M. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.12.1593 · Cited by 20
Neuroprotection for Parkinson’s disease
LeWitt, P. A. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_13 · Cited by 20
de Bernardo, S., Canals, S., Casarejos, M. J., Rodríguez‐Martín, E., & Mena, M. A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10704 · Cited by 20
Regulatory T Cell Therapeutics for Neuroinflammatory Disorders
Harkins, A. L., Kopec, A. L., & Keeler, A. M. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2022045080 · Cited by 19
Experimental Models of HD and Reflection on Therapeutic Strategies
Kim, J., Bordiuk, O. L., & Ferrante, R. J. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00016-x · Cited by 20
Jeong, H. S., Lee, S., Kim, J. E., Lyoo, I. K., Yoon, S. J., Namgung, E., Chang, K.-T., Kim, B. S., Yang, S., Im, J. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189804 · Cited by 19
Cumming, P. D., Pedersen, M. D., Minuzzi, L., Mezzomo, K. M., Danielsen, E. H., Iversen, P., Aagaard, D., Keiding, S., Munk, O. L., & Finsen, B. R. (2006) · Synapse · doi:10.1002/syn.20257 · Cited by 19
Towards New Therapies for Parkinson's Disease
Finkelstein, D. I. (2011) · InTech eBooks · doi:10.5772/954 · Cited by 19
Sharma, H., Hirko, A. C., King, M. A., & Liu, B. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.09.006 · Cited by 20
O′Neill, E., Goisis, R. C., Haverty, R., & Harkin, A. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24420 · Cited by 21
Literature-Related Discovery (LRD)
Kostoff, R. N., Block, J. A., Solka, J. L., Briggs, M. B., Rushenberg, R. L., Stump, J. A., Johnson, D., Lyons, T. J., & Wyatt, J. R. (2007) · Defense Technical Information Center (DTIC) · doi:10.21236/ada473438 · Cited by 19
Nam, J. H., Richie, C. T., Harvey, B. K., & Voutilainen, M. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-65735-5 · Cited by 18
Dual Roles of Microglia in the Basal Ganglia in Parkinson’s Disease
Choudhury, M. E., Kigami, Y., & Tanaka, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083907 · Cited by 18
Minocycline-induced activation of tetracycline-responsive promoter
Chtarto, A., Tenenbaum, L., Velu, T. J., Brotchi, J., Levivier, M., & Blum, D. L. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.067 · Cited by 17
Verma, D., Singh, D. K., Gupta, S., Gupta, P., Singh, A., Biswas, J., & Singh, S. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.01.006 · Cited by 18
Kawasaki, T., Ago, Y., Kitao, T., Nashida, T., Takagi, A., Takuma, K., & Matsuda, T. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.032 · Cited by 18
Goñi‐Allo, B., RAMOS, M., Jordán, J., & Aguirre, N. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.010 · Cited by 18
Ding, L., Nan, W., Zhu, X., Li, X., Zhou, L., Chen, H., Yu, L., Khan, F. U., Zhong, H., & Shi, X. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13062 · Cited by 15
Multi-View Mouse Social Behaviour Recognition With Deep Graphic Model
Jiang, Z., Zhou, F., Zhao, A., Li, X., Li, L., Tao, D., Li, X., & Zhou, H. (2021) · IEEE Transactions on Image Processing · doi:10.1109/tip.2021.3083079 · Cited by 16
Poggini, S., Banqueri, M., Albanese, N. C., Golia, M. T., Ibáñez, F. G., Limatola, C., Fuhrmann, M., Lalowski, M. M., Tremblay, M., Maggi, L., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114295 · Cited by 18
Toki‐to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice
Sakai, R., Irie, Y., Murata, T., Ishige, A., Anjiki, N., & Watanabe, K. (2007) · Phytotherapy Research · doi:10.1002/ptr.2172 · Cited by 17
Therapeutic effects of GM1 on Parkinson's disease in rats and its mechanism
Ba, X.-H. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.996640 · Cited by 17
Morioka, N., Hisaoka‐Nakashima, K., & Nakata, Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_5 · Cited by 17
Metadata
- Authors
- Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S.
- Affiliations
- Pediatrics and Genetics (US)
- Children's Hospital of Philadelphia (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-03-01
- Volume
- 22
- Issue
- 5
- Pages
- 1763-1771
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6758858
- OpenAlex
- W2148726772
- Cited by
- 1,183
- References
- 44
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 13 · 2023: 15 · 2022: 27 · 2021: 41 · 2020: 27 · 2019: 40 · 2018: 47 · 2017: 42 · 2016: 43 · 2015: 43 · 2014: 68 · 2013: 69 · 2012: 63
- FWCI
- 45.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- Parkinson's Disease Foundation (NS38370)
- Muscular Dystrophy Association
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (5r29ns037345-05, NS38370)
- National Institute on Aging (R01-AG13966, R01AG013966)
- National Institute of Neurological Disorders and Stroke (P50-NS38370, R01 NS 38586, R01 NS 42269, R29 NS37345, R01NS042269, R01NS038586, P50NS038370)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, microglial activation, minocycline, MPTP-induced neurotoxicity, neuroprotection, nitrotyrosine, IL-1β, NADPH oxidase, inducible nitric oxide synthase, nigrostriatal dopaminergic neurons, neuroinflammation, iNOS-deficient mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Astrocytes, Corpus Striatum, Disease Models, Animal, Dose-Response Relationship, Drug, Interleukin-1, Mice, Inbred C57BL, Minocycline, Neurons, Substantia Nigra, Tyrosine, Tyrosine 3-Monooxygenase, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Up-Regulation, Microglia, Mice, Knockout, Neuroprotective Agents, Nitric Oxide Synthase, NADPH Oxidases, Parkinsonian Disorders, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review